Experience

Fluidic Analytics

• United Kingdom
• Biotechnology Research
• 1 - 100 Employee

• Principal Protien Scientist

  • Feb 2022 - Present

  Mentoring product assurance team trough validation process (assays, protocol, SOP, documentation, quality control)Biological subject matter expert for concept development

• Principal Protein Scientist

  • Feb 2020 - Jan 2022

  Team leader of product assurance teamValidation and verification process for Fluidity One-M instrumentBiological subject matter expert for Fluidity One-M considering technical risks and customer demand

• Principal Protein Scientist

  • Sep 2018 - Jan 2020

  Line manager for application team to provide data and documentation for the Fluidity One-WBiological subject matter expert for the development and performance testing of the Fluidity One-WFactory acceptance test assay development and documentation for Fluidity One-W

• Senior Scientist

  • Sep 2017 - Sep 2018

  Development of application assays for the Fluidity OneSupporting the development and testing performance of the Fluidity One as a product



AstraZeneca

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Post-doctoral fellow

  • Dec 2014 - Aug 2017

  Development and proof of principle study for cell based high-throughput drug screening using droplet microfluidicsOptimization and validation of co-culture screening assay. Elucidation of fibroblast - cancer cell interaction and the effect on drug resistance.PostDoc representative in the UK for one year. Development and proof of principle study for cell based high-throughput drug screening using droplet microfluidicsOptimization and validation of co-culture screening assay. Elucidation of fibroblast - cancer cell interaction and the effect on drug resistance.PostDoc representative in the UK for one year.



University of Cambridge

• United Kingdom
• Research Services
• 700 & Above Employee

• Post-doctoral fellow

  • Sep 2011 - Nov 2014

  Development of an affinity determination assay using droplet microfluidics and fluorescence anisotropy as a read-out. Development of an enzymatic screening assay in microfluidic droplets (collaboration with MedImmune) Generation of several semi-rational protein libraries in order to understand their way of function. Development of an affinity determination assay using droplet microfluidics and fluorescence anisotropy as a read-out. Development of an enzymatic screening assay in microfluidic droplets (collaboration with MedImmune) Generation of several semi-rational protein libraries in order to understand their way of function.



ETH Zurich

• Switzerland
• Higher Education
• 700 & Above Employee

• PhD

  • Sep 2005 - Jun 2011

  Evolution of several designed protein scaffolds for their binding affinity and catalytic activity. The scaffolds included a catalytic antibody, a computational design binding protein, and an essential enzyme with an altered tertiary structure. Evolution of several designed protein scaffolds for their binding affinity and catalytic activity. The scaffolds included a catalytic antibody, a computational design binding protein, and an essential enzyme with an altered tertiary structure.